Sandra S. Garrett Presented MediMergent’s Disruptive Health IT Platform to BigIdea CONNECTpreneur Forum

Share Article

MediMergent’s National Medication Safety Outcomes and Adherence Program (NMSOAP) collects health information directly from the “Voice of the Patient” without third party interpretation

MediMergent announced today that its CEO, Sandra S. Garrett Ph.D., presented the company’s innovative “Voice of the Patient” software to the BigIdea CONNECTpreneur Forum. The sold-out event was attended by over 300 business leaders and investment groups . Dr. Garrett was among six corporate executives invited to present.    

“It was a great opportunity to present our platform to experts that could provide feedback on our product and services from multi-industry perspectives,” said Sandra S. Garrett, CEO MediMergent, LLC. “Our NMSOAP initiative enrolls patients at point of service, and creates a communication loop among patients, physicians and pharmacists that help track early warning signals related to medications. The majority of the audience is/was a patient and recognized how important it is for patients to know potential adverse effects of their medication and to be able to intervene before costly and dangerous events occur.”

According to Sandra S. Garrett, the CONNECTpreneur Forum is the first of a series of industry events and private investor meetings that MediMergent plans to participate in over the next few months as it scales its business across thousands of pharmacies and physicians to enroll patients and collect real world evidence.

About MediMergent, LLC
MediMergent, LLC is a data collection, integration and analytics company co-founded by Sandra S. Garrett, CEO. or web-based devices, Under a Research Collaboration Agreement with the Center for Drug Evaluation Research (CDER) at the U.S. Food and Drug Administration (FDA), MediMergent established the National Medication Safety, Outcomes and Adherence Program (NMSOAP) to longitudinally assess safety, outcomes, and medication adherence using an innovative, prospective, evaluative approach towards recently approved drugs under real-world conditions. The result is the ability to collect health information directly from patients using the “Voice of the Patient” software without third party interpretation. This information is integrated with other sources of patient information including electronic medical records, pharmacy and claims data to create databases of real-world safety, clinical outcomes, medication compliance, REMS and comparative effectiveness data.

About The BigIdea CONNECTpreneur Forum
Big Idea CONNECTpreneur is a Community of over 3000 Business leaders, CEOs, Entrepreneurs, VCs and angels in the Mid-Atlantic Region. The Forum is a quarterly half-day event featuring networking, news-making speakers and a showcase of 7–8 exciting companies.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sheila Stewart
Visit website